Literature DB >> 3723999

High rate of insufficient antibody titers after single-day immunization with human diploid-cell-strain vaccine against rabies.

M G Täuber, R Putzi, P Fuchs, R Wyler, R Lüthy.   

Abstract

We examined the possibility of simplifying the currently recommended immunization schedule against rabies. Four groups of 11 healthy volunteers were each immunized with either one, two, four, or eight doses of 0.1 ml human diploid cell vaccine (HDCV) intradermally on 1 single day. Antibody titers in serum were determined using a rapid fluorescent focus inhibition test. Geometric mean antibody titers 10, 30 and 90 days after immunization were all greater than 0.5 IU/ml, which is considered protective. A dose-proportional increase in the geometric mean antibody titer was observed for all four groups. However, at each dose level, at least 1 of the 11 volunteers on day 30 and 2 of the 11 volunteers on day 90 had insufficient antibody titers less than 0.5 IU/ml. Single-day immunization against rabies with HDCV vaccine cannot be recommended because of the unacceptably high failure rate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723999     DOI: 10.1007/bf01713059

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  18 in total

1.  A rapid reproducible test for determining rabies neutralizing antibody.

Authors:  J S Smith; P A Yager; G M Baer
Journal:  Bull World Health Organ       Date:  1973-05       Impact factor: 9.408

2.  An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis.

Authors:  M J Warrell; D A Warrell; P Suntharasamai; C Viravan; A Sinhaseni; D Udomsakdi; R Phanfung; C Xueref; J C Vincent-Falquet; K G Nicholson; D Bunnag; T Harinasuta
Journal:  Lancet       Date:  1983-08-06       Impact factor: 79.321

3.  Field evaluations of pre-exposure use of human diploid cell rabies vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1983-11-25       Impact factor: 17.586

4.  Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers.

Authors:  F Y Aoki; D A Tyrrell; L E Hill
Journal:  Lancet       Date:  1975-03-22       Impact factor: 79.321

5.  Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis.

Authors:  M J Warrell; K G Nicholson; D A Warrell; P Suntharasamai; P Chanthavanich; C Viravan; A Sinhaseni; M K Chiewbambroongkiat; X Pouradier-Duteil; C Xueref
Journal:  Lancet       Date:  1985-05-11       Impact factor: 79.321

6.  Multisite intradermal antirabies vaccination. Immune responses in man and protection of rabbits against death from street virus by postexposure administration of human diploid-cell-strain rabies vaccine.

Authors:  K G Nicholson; H Prestage; P J Cole; G S Turner; S P Bauer
Journal:  Lancet       Date:  1981-10-24       Impact factor: 79.321

7.  Use of post-exposure intradermal rabies vaccination in a rural mission hospital.

Authors:  G Harverson; C Wasi
Journal:  Lancet       Date:  1984-08-11       Impact factor: 79.321

8.  Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses.

Authors:  K W Bernard; M A Roberts; J Sumner; W G Winkler; J Mallonee; G M Baer; R Chaney
Journal:  JAMA       Date:  1982-02-26       Impact factor: 56.272

9.  Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon.

Authors:  K G Nicholson; P J Cole; G S Turner; P Harrison
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

10.  Postexposure trial of a human diploid cell strain rabies vaccine.

Authors:  L J Anderson; R K Sikes; C W Langkop; J M Mann; J S Smith; W G Winkler; M W Deitch
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.